Smith & Nephew sells vascular business to InaVein LLC |
|
|
|
Published
:
Mon, 19 Nov 2007 21:00
|
NEW YORK (Thomson Financial) - Smith & Nephew Monday said it's sold its vascular business to InaVein LLC, a private Boston-area investor group. Financial terms weren't disclosed.The business includes Smith & Nephew's Trivex system for the minimally invasive removal of varicose veins and the Tumescent Catheter Inversion systems for the removal of the greater saphenous vein.Shares of Smith & Nephew were off 6 cents to $59.12 in late trading in New York.Michael BaronmbCOPYRIGHTCopyright Thomson Financial News Limited 2007. All rights reserved.The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2792.28 |
22.57 (
0.81 %)
|
| SYMBOL (
2012-01-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
2017.00 |
46.00 (
2.42 %)
|
|
WHITBREAD
(
11:35am )
|
|
1662.99 |
33.99 (
2.09 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
IBM
(
12:34pm ) |
|
181.50 |
0.43 (
0.24 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Makers of orthopedic implants probed 